NUNozomu Uchida

Nozomu Uchida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nozomu Uchida has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Hideki Onishi

    Departments of Psycho-oncology, Saitama Medical University International Medical Center, Saitama, Japan

    18 shared publications
  • Mayumi Ishida

    Departments of Psycho-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan

    13 shared publications
  • Akira Yoshioka

    Department of Medical Oncology and Palliative Care, Mitsubishi Kyoto Hospital, Kyoto, Japan

    11 shared publications
  • Izumi Sato

    Department of Clinical Epidemiology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan

    10 shared publications
  • Mayumi Ishida

    Department of Psycho‐oncology Saitama Medical University International Medical Center Saitama Japan

    6 shared publications
  • Takao Takahashi

    Supportive Medicine, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan

    6 shared publications

Latest Publications

  • Open Access

    Thiamine deficiency in outpatients at a regional cancer centre in Japan: cross-sectional observational study

    by Akira Yoshioka, Mayumi Ishida, Nozomu Uchida, Hideki Onishi, Izumi Sato

    Objective To examine the prevalence of thiamine deficiency and its potential risk factors in cancer outpatients. Methods A cross-sectional study of cancer outpatients aged ≥20 years at a regional hospital in Kyoto, Japan (January–February 2022). Thiamine deficiency was defined as ≤23 ng/mL by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Multivariable logistic regression was used to estimate ORs and 95% CIs for potential risk factors for thiamine deficiency. Results A total of 106 patients were included in this study (mean age 68.3 years, 61% female). Of the 106 patients, 27 (25.5%) had low thiamine levels despite the absence of recognised deficiency symptoms. In multivariable logistic regression analysis, the adjusted OR was 4.05 (95% CI 0.88 to 18.60). Conclusions The prevalence of thiamine deficiency was 25.5% among cancer outpatients without recognised symptoms. An association between low dietary intake and thiamine deficiency was suggested, though further large-scale studies are needed to confirm risk factors and guide management strategies.

  • Open Access

    Thiamine deficiency in cancer patients at initial admission to a palliative care unit: a single-centre cross-sectional study

    by Ryota Sato, Mayumi Ishida, Nozomu Uchida, Yoshitaka Ooya, Izumi Sato, Hiroshi Ito, Akira Yoshioka, Nobuyuki Onizawa, Takao Takahashi, Hideki Onishi

    Objectives: Thiamine deficiency (TD) has been increasingly reported among patients undergoing active cancer treatment. However, its status in end-of-life cancer patients admitted to palliative care units remains unclear. This study aimed to determine the prevalence of TD and associated factors in end-of-life cancer patients on initial admission to a palliative care unit. Methods: This single-centre descriptive cross-sectional study included end-of-life cancer patients admitted for the first time to a palliative care unit between 1 January 2020 and 31 December 2023. Whole blood thiamine concentrations measured on admission were analysed using high-performance liquid chromatography. The TD group was defined as <24.0 ng/mL and the thiamine normal group as 24.0–66.0 ng/mL. Patient characteristics were summarised using descriptive statistics, and factors associated with TD were examined using multivariable logistic regression, adjusting for age and clinical background variables. Results: TD was identified in 85 (36%) of 234 patients. Multivariable logistic regression showed that only a serum albumin level <3.0 g/dL was significantly associated with TD (adjusted OR 2.05, 95% CI 1.10 to 3.90; p=0.023). Age, body mass index, Eastern Cooperative Oncology Group performance status, a history of chemotherapy within 1 month prior to admission and gastrointestinal malignancy were not significantly associated with TD. Conclusion: TD was identified in 36% of end-of-life cancer patients and found to be associated with serum albumin level. In end-of-life cancer patients, particularly those with low serum albumin levels, clinicians should be mindful of the possibility of TD.


  • What can cause cancer patients to attempt suicide? Thiamine deficiency mimicking the symptoms of major depressive disorder

    by Mayumi Ishida, Sho Sato, Izumi Sato, Akira Yoshioka, Nozomu Uchida, Naoki Mizunuma, Kosei Hasegawa, Hideki Onishi

    ObjectivesThiamine deficiency (TD) presents with various physical and psychiatric symptoms, but no cases with depression-like symptoms have been reported.MethodsWe report a patient with cancer who appeared to attempt suicide as a consequence of depressive mood likely related to TD.ResultsThe patient was a 58-year-old woman diagnosed with recurrent endometrial cancer, with lung metastasis and pelvic dissemination. The patient apparently attempted suicide was referred to the psycho-oncology department.At the time of the examination, major depressive disorder was suspected based on her mental symptoms, but when thiamine was administered intravenously in response to her poor dietary intake, her palpitations, dyspnea, anorexia, and insomnia improved, and her suicidal ideation disappeared at her reexamination 1 hour later after thiamine administration.Significance of resultsIt is likely that the observed palpitations, dyspnea, anorexia, and insomnia, as well as the severe depression and the attempted suicide, which were thought to be physical symptoms associated with depression, were actually related to TD. Suicidal ideation and attempted suicide are conspicuous as psychiatric symptoms. However, in such cases, rather than simply starting treatment for depression, it is necessary to consider reversible TD as a cause of these symptoms and perform differential diagnosis to confirm the physical illness.


  • Open Access

    A patient with Marchiafava–Bignami disease type A transported by ambulance with impaired consciousness and malnutrition was successfully treated after early diagnosis by MRI

    by Yoshitaka Ooya, Mayumi Ishida, Nozomu Uchida, Ryota Sato, Akira Yoshioka, Izumi Sato, Hideki Onishi

    Marchiafava–Bignami disease (MBD) is a very rare disorder characterized by demyelination and necrosis of the corpus callosum.A 53‐year‐old male was transported to the emergency room with impaired consciousness. On his arrival, he was quite emaciated. CT examination revealed no hemorrhagic lesions whereas MR images showed hyperintense areas throughout the corpus callosum, leading to a diagnosis of MBD. His impaired consciousness improved with treatment, including parenteral thiamine administration.When examining patients with impaired consciousness because of malnutrition, MBD should be taken in consideration and the incorporation of head MR imaging into the examination protocol enables early diagnosis and treatment, and may improve the prognosis.


  • Naldemedine-induced opioid withdrawal with restlessness as the predominant symptom in a palliative care setting

    by Ryota Sato, Mayumi Ishida, Nozomu Uchida, Takehiko Sakimoto, Takefumi Yamaguchi, Yoshitaka Ooya, Takao Takahashi, Hideki Onishi

    Objectives: Opioid analgesics play a central role in cancer pain treatment; however, it has been reported that opioid-induced constipation (OIC) develops in 80% of patients using opioid analgesics and leads to a decrease in quality of life. Naldemedine improves constipation without affecting the analgesic action of opioid analgesics via peripheral μ-opioid receptors.Methods: We report a terminally ill cancer patient who was diagnosed with opioid withdrawal syndrome (OWS) based on symptoms centered around restlessness and sweating that developed 43 days after administration of naldemedine for OIC.Results: The patient was a 78-year-old woman who was diagnosed with stage IVB uterine sarcoma in October, 1 year prior to her visit to our clinic, and underwent chemotherapy after surgery, but the disease became progressive. Thereafter, metastasis to the fourth thoracic vertebrae (Th4) was identified, and loxoprofen and acetaminophen were started for pain at the metastatic site. Oxycodone hydrochloride hydrate 10 mg/day was additionally administered on postoperative day 11, followed by naldemedine 0.2 mg/day for OIC. On the 43rd day after administration, the patient began to wander the hospital ward in a wheelchair and became noticeably restless. OWS due to naldemedine administration was suspected, and naldemedine was discontinued. The symptoms improved 7 days later, and no similar symptoms were observed thereafter.Significance of results: Patients receiving palliative care often exhibit psychiatric symptoms such as anxiety and depression, but OWS due to naldemedine should also be considered as a potential cause.


  • Open Access

    The prevalence of thiamine deficiency among elderly nursing home residents: A cross‐sectional study

    by Nozomu Uchida, Mayumi Ishida, Izumi Sato, Akira Yoshioka, Takao Takahashi, Daisuke Furuya, Yasuhiro Ebihara, Hiroshi Ito, Hideki Onishi

    Background: Although thiamine deficiency (TD) can lead to Wernicke encephalopathy, the characteristics associated with TD in the elderly have not yet been clarified. We sought to clarify the frequency of TD among an institutionalized elderly population with a controlled dietary intake and to identify possible factors related to TD.Method: We undertook a cross‐sectional study of residents in three nursing homes for the elderly as of June 2020. Blood thiamine concentrations were measured using a high‐performance liquid chromatography method, with TD defined as a concentration of <21.3 ng/mL. Basic data (age, sex, height, weight, and BMI), dietary intake for the previous 3 weeks, degree of care (DOC), degree of independence in daily life for elderly with dementia (DIDLED), and comorbidities were analyzed using descriptive statistical methods.Results: The mean age (±SD) was 86.9 years (±8.29), with 84 residents (70.0%) being female. The DIDLED varied from total independence to long‐term care level 5 (full assistance), with 89.2% suffering dementia. The mean whole blood thiamine value was 36.18 (±17.58) ng/ml, with TD confirmed in 7 (5.8%) of the 120 residents. All TD patients suffered from dementia. No TD was observed in patients with a near‐normal food intake, and no related factors were observed among the other items.Conclusion: Reduced food intake may at increase the risk of TD and symptoms of TD may be overlooked in those displaying symptoms of dementia; thus, it is important for clinicians working with the elderly to remain aware of the potential for TD.


  • Can depressed cancer patients with a borderline thiamine concentration develop deficiency within a short time period?

    by Nozomu Uchida, Mayumi Ishida, Akira Yoshioka, Izumi Sato, Hiroshi Ito, Nobuyuki Onizawa, Ryota Sato, Naoki Mizunuma, Hideki Onishi

    Background Despite increasing reports of thiamine deficiency (TD) among cancer patients, there remain some patients with borderline thiamine concentrations (BTC). However, it is unclear whether such patients subsequently develop TD. Methods Here, we report cases of cancer patients progressing to TD within a short time period after presentation with BTC (24–28 ng/ml). Results Case 1 A 49-year-old female with lung cancer. During treatment for depression, the patient showed a decreased appetite, and a blood sample revealed BTC (25 ng/ml). Fourteen days later, she reported a continued loss of appetite, and despite the absence of the 3 classical signs of Wernicke encephalopathy (WE), additional testing showed a thiamine level of 23 ng/ml, leading to a diagnosis of TD. Case 2 A 65-year-old female developed depression during chemotherapy for angiosarcoma. Her blood sample revealed BTC (25 ng/ml). Seven days later, despite the absence of the classical signs of WE, a further testing revealed a thiamine level of 20 ng/ml. Case 3 A 41-year-old female developed depression during chemotherapy for ovarian cancer. No loss of appetite was observed, but a blood sample revealed BTC (25 ng/ml). Seven days later, despite the absence of the classical signs of WE or decreased appetite, further testing revealed a thiamine level of 19 ng/ml. Significance of results Depressed cancer patients with BTC may develop TD within a short time frame. To prevent TD, health-care professionals should maintain an awareness of its potential and the need for regular testing of thiamine level or prophylactic replacement therapy.


  • Opioid withdrawal syndrome developing after long-term administration of naldemedine

    by Mayumi Ishida, Nozomu Uchida, Akira Yabuno, Kosei Hasegawa, Naoki Mizunuma, Takao Takahashi, Hideki Onishi

    ObjectiveOne of the side effects of opioid administration is opioid-induced constipation (OIC). To address this side effect, the oral peripheral μ opioid receptor antagonist naldemedine was developed. As this drug does not cross the blood–brain barrier, it is thought that it does not lead to opioid withdrawal syndrome (OWS) with central nervous system symptoms.MethodsHere, we report a cancer patient who presented with symptoms centered round anxiety and irritation 4 months after administration of naldemedine for OIC and who was diagnosed with OWS after close investigation.ResultsThe patient was a 65-year-old female who had surgery for stage IB endometrial cancer 4 years previously, but experienced recurrence involving the pelvis 2 years later. Medical narcotics were used to control pain, but naldemedine was started to control subsequent constipation. When naldemedine-related OWS was suspected and the administration of naldemedine discontinued, the above symptoms disappeared within two days, and no recurrence was observed thereafter.Significance of the resultsFor patients receiving naldemedine, it is necessary to consider the possibility of OWS regardless of the period of administration in order to maintain patient quality of life.


  • Open Access

    Is a decrease in activities of daily living in the elderly irreversible? A case report of Wernicke encephalopathy in home medical care

    by Nobuyuki Onizawa, Mayumi Ishida, Nozomu Uchida, Izumi Sato, Akira Yoshioka, Hiroshi Ito, Hideki Onishi

    The patient was an 83‐year‐old male who, after being hospitalized for 70 days for suffocation due to aspiration, was provided with home medical care (HMC) as his physical condition did not allow him to climb stairs. Wernicke encephalopathy (WE) was suspected based on his disorientation and a continued loss of appetite. This diagnosis was supported by abnormal serum thiamine and the disappearance of delirium after thiamine administration. In addition, he became able to use stairs. Patients who receive HMC should undergo active screening and receive treatment with WE in mind.


  • A case of Wernicke encephalopathy arising in the early stage after the start of hemodialysis

    by Nayuta Seto, Mayumi Ishida, Tatsuya Hamano, Hideki Onishi, Nozomu Uchida

    Wernicke encephalopathy (WE) resulting from vitamin B1 (VB1) deficiency is commonly regarded as being associated with a high alcohol intake; however, recently many non-alcohol-related cases have been reported. Herein, we report a case of WE due to VB1 deficiency in the early stage after the start of hemodialysis. The patient was a 79-year-old male recommended for hemodialysis due to chronic renal failure. He was admitted to our hospital due to a hemorrhagic duodenal ulcer, but hemodialysis was started as the result of exacerbation of renal function. After the start of 3-times-weekly hemodialysis, the patient’s general condition was settled and he was able to consume about half his usual dietary intake. Seventeen days after the start of hemodialysis, impaired consciousness and involuntary movements appeared, and subsequent head magnetic resonance imaging showed increased signal intensity around the cerebral aqueduct. VB1 administration based on a suspicion of WE resulted in a significant improvement in neurological symptoms and no sequelae were observed. Hemodialysis may be a risk factor for VB1 deficiency. When a dialysis patient presents with psychiatric symptoms or impaired consciousness, in particular, it is important to always keep the possibility of VB1 deficiency in mind.